Since FGF-10 upregulation has been implicated in breast cancer (Theodorou et al., 2004), we used MDA-MB-231 and MCF-7 breast cancer cell lines as models in which to overexpress recombinant PEA3. This evidence concerns the gene FGF10 and breast cancer.